Prevalence in relation to the characteristics of the women enrolled in the trial
| CT positive (n) | Tested (n) | Prevalence (%) | p Value | |
|---|---|---|---|---|
| Age (years) | <0.001 | |||
| <20 | 12 | 76 | 15.8 | |
| 20–29 | 34 | 490 | 6.9 | |
| 30–39 | 11 | 461 | 2.4 | |
| 40–49 | 5 | 233 | 2.1 | |
| 50–59 | 0 | 72 | 0 | |
| 60–69 | 0 | 20 | 0 | |
| 70–79 | 0 | 12 | 0 | |
| >80 | 0 | 1 | 0 | |
| Unknown | 0 | 3 | 0 | |
| Postcoital bleeding | <0.04 | |||
| Yes | 6 | 59 | 10.2 | |
| No | 52 | 1241 | 4.2 | |
| Unknown | 4 | 68 | 5.9 | |
| Ethnic origin | NS | |||
| European | 20 | 568 | 3.5 | |
| Mediterranean | 10 | 275 | 3.6 | |
| African | 4 | 51 | 7.8 | |
| Creole | 5 | 67 | 7.5 | |
| Hindu | 12 | 236 | 5.1 | |
| Asian | 3 | 48 | 6.3 | |
| Hispanic | 3 | 27 | 11.1 | |
| Other/unknown | 5 | 96 | 5.2 | |
| Contraceptive method | NS | |||
| Non | 32 | 733 | 4.4 | |
| Condom | 4 | 97 | 4.1 | |
| Oral contraceptive | 22 | 324 | 6.8 | |
| Other | 3 | 162 | 1.9 | |
| Unknown | 1 | 52 | 1.9 |